Bain Linda — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Bain Linda has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

Linda Bain serves as a director of Arvinas, Inc., a publicly traded biotechnology company focused on developing targeted protein degradation therapies. The most recent SEC filing dating 2026-06-26 lists Bain as a board member of Arvinas, Inc. Beyond this filing, there is limited publicly available information about her professional background. The context here is limited to her role as a director per the SEC filing.

Board memberships

• Arvinas, Inc.

Awards & honors

• Director at Arvinas, Inc. (as of 2026-06-26)

Recent Transactions

Companies — Last 90 Days

• Autolus Therapeutics plc (AUTL) — 1 filings, last 2026-07-01
• ARVINAS, INC. (ARVN) — 1 filings, last 2026-06-26

Frequently Asked Questions

Who is Bain Linda?

Linda Bain serves as a director of Arvinas, Inc., a publicly traded biotechnology company focused on developing targeted protein degradation therapies. The most recent SEC filing dating 2026-06-26 lists Bain as a board member of Arvinas, Inc. Beyond this filing, there is limited publicly available information about her professional background. The context here is limited to her…

How many SEC Form 4 filings has Bain Linda submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Bain Linda's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week